Published Date: 13 Mar 2023
Pregnant women's use of asthma medications is not associated with an increased risk of autism, ADHD or Tourette's syndrome, a new study has found.
Read Full NewsOn World Oxygen Day, the COPD Foundation's Mike Hess outlines the stigma, training gaps, and Medicare barriers affecting patients on supplemental oxygen.
Schleich says biologic switching in severe asthma should follow exacerbation phenotyping and discusses response predictors and standardized follow-up.
A post-hoc PREDMETH analysis presented at ERS 2026 links lower baseline FVC and shorter disease duration with greater FVC gains on first-line therapy.
Vanzacaftor Regimen Lets Some Children With Cystic Fibrosis Stop PERT
Q&A: Curcumin Lowers IL-17 in COPD, With Retno Ariza Soemarwoto, MD
A retrospective 10-center U.S. study found stiripentol reduced convulsive seizure frequency, status epilepticus episodes, and emergency health care use in patients with Dravet syndrome.
Newly presented post hoc analyses examined diazepam nasal spray for status epilepticus in seizure clusters and intervals between clusters in children, alongside real-world data on rescue medication prescribing.
1.
FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials
2.
Cardiomyocytes are shielded from chemotherapy damage by mitochondrial proteins.
3.
FDA Expands Durvalumab Label to Operable Lung Cancer
4.
France Expands 2026 Vaccination Rules Amid Resurgence
5.
Can Response-Adapted Surgery Improve Outcomes in HNSCC?
1.
Progressive Models in Hematology for Healthcare Excellence
2.
Targeted RNA Delivery to Tumors: Mechanisms, Clinical Implications, and Future Directions
3.
Precision Oncology Advances: Neoantigen Therapies, TCR Strategies & Radiotherapy Innovations
4.
Molecular Matching for Individualized Blood-Disorder Therapy
5.
Advanced Pathways in Oncology for Better Care
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation